| Product Information |
DR-XY48835_PI_01.pdf
|
| Registration Number |
DR-XY48835
|
| Generic Name |
Cabotegravir (as sodium)
|
| Brand Name |
Apretude
|
| Dosage Strength |
30mg
|
| Dosage Form |
Film-Coated Tablet
|
| Classification |
Prescription (Rx) Drug
|
| Pharmacologic Category |
-
|
| Packaging |
White opaque HDPE bottle with white opaque PP child-resistant closure and PE-faced induction heat seal-liner x 30 tablets (Box of 30 tablets)
|
| Manufacturer |
Glaxo Operations UK Limited (trading as Glaxo
Wellcome Operations
|
| Country of Origin |
United Kingdom
|
| Trader |
ViiV Healthcare UK Limited
|
| Importer |
GlaxoSmithKline Philippines, Inc.
|
| Distributor |
GlaxoSmithKline Philippines, Inc.
|
| Application Type |
Monitored Release
|
| Issuance Date |
03 August 2023
|
| Expiry Date |
03 August 2028
|